Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives
Cancer Treatment Reviews · 2025-11 · 140 · 103023
DOI: 10.1016/j.ctrv.2025.103023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2025-11. Verfasst von Vincenzo Di Lauro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Napoli, Italy. Hauptthemen laut MEDLINE: Immunoconjugates, Antibodies, Monoclonal, Humanized, Breast Neoplasms, Topoisomerase I Inhibitors. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 106 Literaturangaben. Gefördert von: Fondazione Umberto Veronesi.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Napoli, Italy.
- S.S.D. C.O.r.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. Electronic address: Rizzo.alessandro179@gmail.com.
- Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Napoli, Italy; Scuola Superiore Meridionale (SSM), Clinical and Translational Oncology, Naples, Italy; Division of Med…
- Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
- Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Napoli, Italy; Scuola Superiore Meridionale (SSM), Clinical and Translational Oncology, Naples, Italy.
- Scuola Superiore Meridionale (SSM), Clinical and Translational Oncology, Naples, Italy; Division of Medical Oncology, Department of Clinical Medicine, University of Naples Federico II, Naples, Italy.
Förderung
- Fondazione Umberto Veronesi
Zitieren
APA
Di Lauro, V., Rizzo, A., Tafuro, M., Fina, E., Martinelli, C., Calderaio, C., Di Rienzo, R., Pirolo, M., Fanizzi, A., Massafra, R., & De Laurentiis, M. (2025). Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives. Cancer Treatment Reviews, 140, 103023. https://doi.org/10.1016/j.ctrv.2025.103023
Vancouver
Di Lauro V, Rizzo A, Tafuro M, Fina E, Martinelli C, Calderaio C, et al. Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives. Cancer Treatment Reviews. 2025;140:103023. doi:10.1016/j.ctrv.2025.103023
BibTeX
@article{DiLauro2025,
author = {Di Lauro, Vincenzo and Rizzo, Alessandro and Tafuro, Margherita and Fina, Emanuela and Martinelli, Claudia and Calderaio, Claudia and Di Rienzo, Rossana and Pirolo, Miriam and Fanizzi, Annarita and Massafra, Raffaella and De Laurentiis, Michelino},
title = {Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives},
journal = {Cancer Treatment Reviews},
year = {2025},
volume = {140},
pages = {103023},
doi = {10.1016/j.ctrv.2025.103023}
}
EUVIMED